Form4insider filings, from the source

SEC Form 4 · accession 0001106578-26-000116

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Aug 7, 2026
Accepted (ET)
Aug 10, 2026 · 4:38 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Aug 7, 2026M9,500$135.42A333,943Iby Trust
Common StockF3,F2Aug 7, 2026S357$525.2859D333,586Iby Trust
Common StockF4,F2Aug 7, 2026S1,112$526.1488D332,474Iby Trust
Common StockF5,F2Aug 7, 2026S411$526.8153D332,063Iby Trust
Common StockF6,F2Aug 7, 2026S240$527.7183D331,823Iby Trust
Common StockF7,F2Aug 7, 2026S709$529.1375D331,114Iby Trust
Common StockF8,F2Aug 7, 2026S1,450$530.3167D329,664Iby Trust
Common StockF9,F2Aug 7, 2026S2,781$531.3045D326,883Iby Trust
Common StockF10,F2Aug 7, 2026S183$532.0097D326,700Iby Trust
Common StockF11,F2Aug 7, 2026S160$533.3675D326,540Iby Trust
Common StockF12,F2Aug 7, 2026S200$534.266D326,340Iby Trust
Common StockF13,F2Aug 7, 2026S160$535.3075D326,180Iby Trust
Common StockF14,F2Aug 7, 2026S360$536.9946D325,820Iby Trust
Common StockF15,F2Aug 7, 2026S625$538.5448D325,195Iby Trust
Common StockF16,F2Aug 7, 2026S632$539.1418D324,563Iby Trust
Common StockF17,F2Aug 7, 2026S120$540.32D324,443Iby Trust
Common Stockholding———40,513D
Common Stockholding———166Iby Spouse
Common StockF18holding———249,108Iby Trust
Common StockF19holding———45,596Iby Trust
Common StockF20holding———8,902Iby Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF21$135.42Aug 7, 2026M9,500DMar 15, 2023Mar 15, 2027Common Stock9,500179,910I

Explanation of responses